Indeed, early 2015 year a couple VC friends warned me that Theranos was a bunch of crock and everyone knew it, and that it was going to be the company that would send rippled through the venture market in 2016. Well 2016 was sure a cold year for venture. When I think about Elizabeth as an entrepreneur, on one hand I respect her for trying something so audacious, and sticking with it for so long. However, the one thing that the valley doesn't teach you (in fact quite the opposite) is that there are actually almost no short cuts in startup, get capital and deploy it building a strong and resilient product and business around it, then take it to market. Elizabeth got really caught up in taking absolutely nothing feasible to market, and that's a damn shame.